抑制LINE1衍生的MET转录会诱导癌细胞的亡和coprotein敲击
Umberto Miglio1, Enrico Berrino1,2, Daniele Avanzato3
1Candiolo Cancer Institute, FPO-IRCCS, Candiolo, 10060 Candiolo, TO, Italy.
Molecular therapy. Nucleic acids
|April 28, 2025
概括
针对MET瘤基因中的特定元素L1-MET,有效地降低了癌细胞的活力,并促进了细胞亡. 这种方法在治疗对MET和EGFR等瘤基因成的瘤方面表现有前途.
科学领域:
- 分子生物学分子生物学
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
背景情况:
- 基因内长间隔核元素1 (LINE1s) 可以创建破坏基因转录的嵌合序列.
- 位于介质细胞上皮质过渡 (MET) 瘤基因内的L1-MET与瘤发育和进展有关.
研究的目的:
- 为了研究针对L1-MET的效果,在各种癌症细胞系中使用修饰的反感性寡核酸.
- 评估L1-MET抑制对细胞活力,细胞亡和基因表达特征的影响.
主要方法:
- 利用修改后的反意义寡核酸来专门针对L1-MET.
- 在八个癌症细胞系 (乳腺,肺,胃肠道) 和非转化的人类细胞中测试了效果.
- 分析了细胞活力,细胞亡和蛋白质表达 (MET,EGFR) 的变化.
主要成果:
- 抑制L1-MET降低了癌细胞活力和增加了细胞亡.
- 观察到MET和表皮生长因子受体 (EGFR) 蛋白的下调.
- 在具有MET放大或EGFR突变的细胞和依赖MET/EGFR信号的细胞中,效应更为明显.
结论:
- 针对L1-MET有效降低MET和EGFR蛋白质水平.
- 抑制L1-MET显示出作为消除瘤基因成的瘤细胞的策略的潜力.
- 这种方法可能为克服当前向癌症治疗的局限性提供了一种方法.
相关概念视频
Eukaryotic Transcription Inhibitors
9.7K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
9.7K
Non-LTR Retrotransposons
11.3K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.3K
RNA Interference
25.7K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
25.7K
Experimental RNAi
6.0K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.0K
piRNA - Piwi-interacting RNAs
6.7K
PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
6.7K
siRNA - Small Interfering RNAs
16.3K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.3K


